University Health Network
π¨π¦Canada
- Country
- π¨π¦Canada
- Ownership
- Private
- Established
- 1999-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.uhn.ca
CYP2C19 Genotype-Specific Dosing Plus TDM on Reaching Therapeutic Voriconazole Blood Levels
Phase 4
Completed
- Conditions
- Aspergillosis InvasiveFungal Infection
- Interventions
- Drug: Standard of CareGenetic: Voriconazole genotype-specific dosing
- First Posted Date
- 2018-11-06
- Last Posted Date
- 2020-11-03
- Lead Sponsor
- University Health Network, Toronto
- Target Recruit Count
- 30
- Registration Number
- NCT03731169
- Locations
- π¨π¦
Toronto General Hospital, Toronto, Ontario, Canada
π¨π¦Princess Margaret Cancer Care Centre, Toronto, Ontario, Canada
Perioperative ACT-Based Clinical Hypnosis for Opioid Weaning
Not Applicable
Completed
- Conditions
- Post-Surgical Pain
- Interventions
- Behavioral: Clinical Hypnosis
- First Posted Date
- 2018-11-05
- Last Posted Date
- 2020-12-07
- Lead Sponsor
- University Health Network, Toronto
- Target Recruit Count
- 92
- Registration Number
- NCT03730350
- Locations
- π¨π¦
Toronto General Hospital, Toronto, Ontario, Canada
Bariatric Surgery: Microbiome & Diabetes
Active, not recruiting
- Conditions
- Obesity
- First Posted Date
- 2018-10-29
- Last Posted Date
- 2022-11-02
- Lead Sponsor
- University Health Network, Toronto
- Target Recruit Count
- 120
- Registration Number
- NCT03723486
- Locations
- π¨π¦
University Health Network, Toronto General Hospital, Toronto, Ontario, Canada
Multi-Omic Assessment of Squamous Cell Cancers Receiving Systemic Therapy
Active, not recruiting
- Conditions
- Squamous Cell Carcinoma of the Head and NeckCancerMetastatic CancerAnal Canal Squamous Cell CarcinomaEsophagus Squamous Cell Carcinoma
- First Posted Date
- 2018-10-19
- Last Posted Date
- 2025-01-30
- Lead Sponsor
- University Health Network, Toronto
- Target Recruit Count
- 39
- Registration Number
- NCT03712566
- Locations
- π¨π¦
Princess Margaret Cancer Centre, Toronto, Ontario, Canada
Outcomes Following Omission of Daily Routine Chest Radiographs Following Pulmonary Resection
Phase 2
Completed
- Conditions
- Lung Cancer, Nonsmall CellLung AdenocarcinomaLung CancerLung DiseasesSurgery
- Interventions
- Diagnostic Test: Chest XrayDiagnostic Test: No daily chest xray
- First Posted Date
- 2018-10-15
- Last Posted Date
- 2020-05-01
- Lead Sponsor
- University Health Network, Toronto
- Target Recruit Count
- 50
- Registration Number
- NCT03704870
- Locations
- π¨π¦
Toronto General Hospital, Toronto, Ontario, Canada
Palliative Thoracic ImmunoRT
Recruiting
- Conditions
- Lung Cancer, Nonsmall CellLung Cancer
- First Posted Date
- 2018-10-15
- Last Posted Date
- 2025-02-20
- Lead Sponsor
- University Health Network, Toronto
- Target Recruit Count
- 30
- Registration Number
- NCT03705806
- Locations
- π¨π¦
University Health Network, Princess Margaret Cancer Centre, Toronto, Ontario, Canada
Liquid Biopsy Evaluation and Repository Development at Princess Margaret
Recruiting
- Conditions
- Colon CancerUterine CancerLung CancerBRCA1 MutationBRCA2 MutationKidney CancerLeukemiaMutationCowden SyndromeBreast Cancer
- First Posted Date
- 2018-10-11
- Last Posted Date
- 2024-08-21
- Lead Sponsor
- University Health Network, Toronto
- Target Recruit Count
- 2500
- Registration Number
- NCT03702309
- Locations
- π¨π¦
Princess Margaret Cancer Centre, Toronto, Ontario, Canada
Feasibility Study of MET-4: Evaluating Fecal Microbiome Effects in Immunotherapy Patients
- First Posted Date
- 2018-09-26
- Last Posted Date
- 2025-03-30
- Lead Sponsor
- University Health Network, Toronto
- Target Recruit Count
- 65
- Registration Number
- NCT03686202
- Locations
- π¨π¦
Princess Margaret Cancer Centre, Toronto, Ontario, Canada
Recombinant Subunit Herpes Zoster Vaccine in VZV-Seronegative Organ Transplant Recipients
Phase 3
Completed
- Conditions
- Varicella Zoster Vaccine
- Interventions
- Biological: recombinant subunit Herpes zoster vaccine
- First Posted Date
- 2018-09-26
- Last Posted Date
- 2020-08-05
- Lead Sponsor
- University Health Network, Toronto
- Target Recruit Count
- 23
- Registration Number
- NCT03685682
- Locations
- π¨π¦
University Health Network, Toronto General Hospital, Multi-Organ Transplant, Toronto, Ontario, Canada
Impact of Sugammadex vs. Neostigmine Reversal on Post-Operative Recovery and Complications
Phase 4
Completed
- Conditions
- Obstructive Sleep Apnea
- Interventions
- First Posted Date
- 2018-09-20
- Last Posted Date
- 2025-03-20
- Lead Sponsor
- University Health Network, Toronto
- Target Recruit Count
- 120
- Registration Number
- NCT03679611
- Locations
- π¨π¦
Toronto Western Hospital, Toronto, Ontario, Canada
Β© Copyright 2025. All Rights Reserved by MedPath